Recently, it has been reported that NLRP3 inflammasome activation serves as a triggering mechanism leading to glomerular injury and ultimate end-stage renal disease (ESRD) under different pathological conditions (Yi et al., 2006; Abais et al., 2014a). The gene discussed is NLRP3; the disease is stage 5 chronic kidney disease.